[1] |
HU Kangyi, CAO Linzhong, WAN Chaochao, SHANG Zhengya, YANG Xiaorui, ZHANG Yongjie.
Research progress of traditional Chinese medicine regulating mitochondrial function in the treatment of steroid-induced femoral head necrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 688-696.
|
[2] |
QIN Wenxiu, XU Junfeng, YANG Ting, WANG Pingfei.
Research progress on signaling pathway of tanshinoneIIA in treatment of nerve injury after ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 705-713.
|
[3] |
LI Yanyang, WANG Yunjiao, LV Shichao.
Effects and mechanism of traditional Chinese medicine injection in prevention and treatment of cardiotoxicity induced by antineoplastic drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 572-577.
|
[4] |
LI Shuang, HAN Shuzhen, DAI Yuting, XIU Minghui, DU Xianqin, HE Jianzheng, LIN Xingyao.
Progress in the prevention and treatment of traditional Chinese medicine based on the mechanism of intestinal injury of various chemotherapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 583-593.
|
[5] |
QI Xiaofeng, LUO Yali, XIAO Mengyong, ZHOU Shiqin, ZHOU Wen, AN Fangyu, WEI Benjun, LIU Yongqi.
Research status of dialectical prevention and treatment of acute lung injury based on the theory of "Wei qi and Ying Xue"
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 429-437.
|
[6] |
HOU Xiaoyu, LENG Yufang, CAO Xuefen, LV Xingjiao, HAN Xiaoxia, Janvier NIBARUTA, LIU Yongqiang.
Network analysis and experimental verification of Schisandrin B reduces intestinal ischemia reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 147-154.
|
[7] |
ZHANG Li, WANG Jin, LI Huizi, PENG Hui, HE Jun, PENG Shuangqing, GUO Jiabin.
Role of Nrf2 pathway in flutamide-induced mitochondrial biogenesis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 498-504.
|
[8] |
CHEN Shengfu, LI Xiaolin, WANG Weigang, DU Weize, LI Maoxing.
Research progress on antipyretic effect of Chinese medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 334-344.
|
[9] |
WANG Xiaolin, GAO Pan, ZOU Yunzeng.
Association between mitochondrial oxidative stress and diabetic cardiomyopathy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1080-1085.
|
[10] |
LIU Xiaoping, LAI Xiangmao, OUYANG Zizhang, JIANG Sheng, ZHANG Ying.
Nobiletin inhibits neonatal rat cardiomyocytes hypertrophy induced by high glucose
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 753-759.
|
[11] |
CHEN Ying, YUAN Yonggui.
Research progress in the treatment of depression with monome of Chinese herb, drug pairs, compound prescriptions and Chinese patent drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 586-593.
|
[12] |
YIN Yujie, CHANG Liping.
Pharmacological research and clinical applications progress of Lianhua Qingwen capsules/granules in respiratory diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1174-1180.
|
[13] |
MU Xin, ZHAO Ying, ZHANG Lan, CUI Yimin, ZHANG Yongxiang, DU Guanhua.
Drug clinical trial of COVID-19 in China: A brief analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 869-877.
|
[14] |
FENG Rui, ZHANG Jiali, HE Mingchao, LI Yue, ZHANG Yan.
Pharmacological targets and clinical application of traditional Chinese medicine and active components in the prevention and treatment for depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 467-474.
|
[15] |
LU Yubao, CHEN Yutong, HE Gege, CAI Zongyan, CHENG Yue, CHENG Zihua, GUO Jiamin, GUO Yanzhi.
Application of traditional Chinese medicine extract in repairing spinal cord injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1075-1080.
|